Both in Biotechnology
Calidi Biotherapeutics vs Curis
Over the past year CLDI returned −96.9% and CRIS returned −97.6%; their daily moves had a correlation of -0.01.
CLDI −96.9% CRIS −97.6%Growth of $1, one year, split-adjusted
| Metric | CLDI | CRIS |
|---|---|---|
| Price | $0.7490 | $0.7139 |
| Market cap | $1.9M | $1.7M |
| Today | +13.83% | +8.00% |
| 1 month | −28.7% | −9.5% |
| 6 months | −77.9% | −93.7% |
| Year to date | −96.0% | −96.4% |
| 1 year | — | −97.6% |
| Revenue growth (YoY) | — | −100.0% |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | 0.4× |
| Net cash | $3.1M | $5.1M |
| Dividend yield | — | — |
| Volatility (60d) | 82.6% | 146.2% |
| Short % of float | 0.9% | 23.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).